Maqola

Neurodevelopmental outcomes in children with HIV infection under 3 years of age

Caroline FosterThe Family Clinic, St Mary's Hospital, Praed Street, London, UKR L BiggsThe Family Clinic, St Mary's Hospital, Praed Street, London, UKDiane MelvinThe Family Clinic, St Mary's Hospital, Praed Street, London, UKM D S WaltersThe Family Clinic, St Mary's Hospital, Praed Street, London, UKGareth Tudor‐WilliamsThe Family Clinic, St Mary's Hospital, Praed Street, London, UKE G Hermione LyallThe Family Clinic, St Mary's Hospital, Praed Street, London, UK

2007en

ABI

Annotatsiya

Following the introduction of combination antiretroviral therapy, children vertically infected with the human immunodeficiency virus (HIV-1) living in the developed world are surviving into adult life. This paper reviews the neurodevelopmental outcomes of 62 consecutively-presenting children with HIV-1 infection diagnosed before 3 years of age (32 males, 30 females; median age at presentation 6mo). Neurological and developmental data are presented with immunological and virological responses to antiretroviral therapy. Fourteen children (22%) had abnormal neurological signs and 25 (40%) demonstrated significant developmental delay on standardized developmental assessments. Children presenting with more severe HIV-1 disease and immune compromise had significantly more abnormal neurological signs and developmental delays than children presenting with milder HIV-1 symptomatology. Immune function, control of HIV-1 viral replication, and growth parameters improved with antiretroviral therapy (median age at last follow-up 7y 3mo); however, abnormal neurological signs and significant gross motor difficulties persisted.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1111/j.1469-8749.2006.tb01339.x

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar